Immune thrombocytopenia in a 22‐year‐old post Covid‐19 vaccine. - GreenMedInfo Summary
Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine.
Am J Hematol. 2021 05 1 ;96(5):E133-E134. Epub 2021 Feb 11. PMID: 33476455
Omar Tarawneh
A 22‐year‐old healthy male with no medication use received the Pfizer‐BioNTech BNT16B2b2 mRNA vaccine through his work as an emergency department employee. On day three, post‐vaccination, he experienced widespread petechiae (Figure (Figure1)1) and gum bleeding, which prompted his presentation. He was current on his vaccines, including yearly influenza, with no history of adverse reactions. He denied respiratory and gastrointestinal complaints or a history of infection. He had no personal or family history of bleeding or autoimmune disease. Vital signs and the remainder of his exam were normal. Laboratory tests revealed normal white‐cell count, hemoglobin, and severe thrombocytopenia with a platelet count of 2 × 109/L.